Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
322.00    0.00 (0.00%)
Bid:
325.50
Ask:
330.00
Spread: 4.50 (1.382%)
Market Cap: £104.30m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Result of AGM

28 May 2026 07:00

RNS Number : 9575F
Accesso Technology Group PLC
28 May 2026
 

28 May 2026

accesso® Technology Group plc

 

("accesso" or the "Company")

 

Results of Annual General Meeting

 

accesso Technology Group plc (AIM: ACSO), announces that at its Annual General Meeting ("AGM"), held at 2.00 pm on Wednesday 27 May 2026 all resolutions put to the meeting were duly passed on a poll vote.

 

The full text of the resolutions considered at the AGM is set out in the Notice of AGM published on 22 April 2026, available on the Company's website: www.accesso.com

 

Results of the poll vote on each resolution are set out below:

 

Resolution

For

Against

Withheld

 

1

To receive the Audited Financial Statements for the year ended 31 December 2025

 

21,289,675

 

49

 

55,030

 

2

To approve the Annual Report on Remuneration for the financial year ended 31 December 2025

 

19,184,862

 

522,299

 

1,637,593

 

3

Re-appoint William Russell

 

21,095,036

 

249,536

 

182

 

 

4

Re-appoint Matthew Boyle

 

21,249,651

 

94,921

 

182

 

5

Re-appoint Jody Madden

 

21,197,490

 

132,556

 

14,708

 

6

Re-appoint Andrew Malpass

 

21,097,132

 

232,914

 

14,708

 

7

Re-appoint Brian Nelson

 

21,253,722

 

90,850

 

182

 

8

To appoint Grant Thornton UK LLP as Auditor

 

21,343,749

 

851

 

154

 

9

To authorise the Directors to determine the Auditor's remuneration

 

21,344,512

 

88

 

154

 

10

To renew the Directors' authority to allot securities

 

20,652,993

 

691,581

 

180

 

11

To waive shareholders' rights of pre-emption

 

20,739,383

 

605,191

 

180

 

12

To waive shareholders' rights of pre-emption in connection with an acquisition or specified capital investments

 

20,809,623

 

534,951

 

180

 

13

To authorise the Company to make market purchases of its own shares

 

21,133,803

 

160,066

 

50,885

 

 

 

For further information, please contact:

 

accesso Technology Group plc

+44 (0)118 934 7400

Lee Cowie, Chief Executive Officer

Matthew Boyle, Chief Financial Officer

 

Deutsche Numis (Nominated Adviser and Sole Broker)

+44 (0)20 7260 1000

Joshua Hughes, Iqra Amin

 

DGA Group

+44 (0)20 7550 9225

Adam Davidson, Corbin Ellington

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUBARRNUUVUUR
Date   Source Headline
30th Jun 20267:00 amRNSDirector/PDMR Shareholding
25th Jun 202611:32 amRNSDirector/PDMR Shareholding
5th Jun 20267:00 amRNSHolding(s) in Company
28th May 20266:00 pmRNSHolding(s) in Company
28th May 20267:00 amRNSResult of AGM
18th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSChief Executive Officer Succession
29th Apr 20267:00 amRNSAnnual Report and Notice of AGM
22nd Apr 20267:00 amRNSAppointment of Non-Executive Director
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAcquisition of Dexibit
30th Mar 20267:00 amRNSFinal Results
20th Mar 20266:05 pmRNSHolding(s) in Company
18th Mar 20264:54 pmRNSCompletion of Tender Offer & Total Voting Rights
13th Mar 20261:34 pmRNSResult of Tender Offer
13th Mar 20261:28 pmRNSResult of General Meeting
11th Feb 20267:00 amRNSTender Offer
10th Feb 20267:00 amRNS-RExpansion of Strategic Partnership with Adyen
6th Feb 20263:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSTrading Update and Tender Offer
9th Jan 20265:30 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTrading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20256:02 pmRNSHolding(s) in Company
22nd Dec 20256:02 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 202511:33 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.